This week in drug discovery (13-17 June)

News round-up by DDW’s Reece Armstrong for 13-17 June.

Partnerships, awards, and new companies are some of the topics of this week’s news round-up.

Bachem & Eli Lilly partner on oligonucleotide project

Swiss pharmaceutical company Bachem has partnered with Eli Lilly on a seven-year agreement to advance the development of oligonucleotide-based drug substances.

KBI Biopharma & Selexis open integrated manufacturing facility

Contract manufacturing organisation (CMO) KBI Biopharma and cell line development company Selexis have opened an integrated facility in Geneva, Switzerland.

Celerion takes industry award for seventh year running

Clinical research organisation (CRO) Celerion has been recognised for its contributions to the industry by claiming an award for the seventh consecutive year.

Spirea raises £2.4m to develop ADC cancer therapies

A University of Cambridge spin-out has secured £2.4 million of investment to help it develop a pipeline of antibody drug conjugate (ADC) therapies for solid tumours.

GADx launches as social enterprise for diagnostics  

Diagnostics company Mologic and its sister company Global Access Diagnostics (GAD) have combined their expertise to form a new business aimed at addressing the gaps in the provision of diagnostics, with a focus on expanding affordable access to quality tests.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free